Recordati operates directly in France, Germany, Greece, Ireland, Italy, Portugal, Russia and C.I.S.,Spain and United Kingdom. In these countries, it not only markets original pharmaceutical specialties, but also innovative in-licensed pharmaceuticals.

Thanks to numerous licensing agreements with international pharmaceutical companies, Recordati's innovative proprietary pharmaceuticals (lercanidipine, flavoxate, fenticonazole) are distributed in approximately 100 countries.